Improving Outcome of Very Preterm Infants Using Collaborative Quality Improvement

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

WITHDRAWN

Clinical Phase

NA

Study Classification

INTERVENTIONAL

Study Start Date

2024-10-01

Study Completion Date

2026-09-30

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

A multicenter interventional study using evidence-based collaborative quality improvement to reduce mortality and major morbidities of very preterm infants in six neonatal centers in Shanghai

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Comparison of Care Practices, Mortality and Morbidity of Very Preterm Infants Between Two Tertiary Centers in Northwest and South of China

NCT05116670

Morality Morbidity;Newborn Very Preterm Maturity of Infant

COMPLETED

Systemic Management in Extremely Preterm and Extremely Low Birth Weight Infants

NCT06082414

Bronchopulmonary Dysplasia Death

COMPLETED

Quality Improvement to Reduce Mortality or Severe Intracranial Hemorrhage in Neonatal Extracorporeal Life Support

NCT05075486

Extracorporeal Life Support Extracorporeal Membrane Oxygenation Quality Improvement +3 more

WITHDRAWN NA

Cohort Construction for Preterm Infants With Growth Retardation and Its Influencing Factors

NCT04817878

Problem With Growth of an Infant

UNKNOWN

Risk Factors of Preterm Birth Born in Hospital：a Prospective Multicenter Case-control Study

NCT03602625

Risk Factors

COMPLETED

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

A multicenter interventional study using evidence-based collaborative quality improvement to reduce mortality and major morbidities of very preterm infants using evidence-based collaborative quality improvement interventions including benchmarking, potential better practice list, PDSA implementation and collaborative learning.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Morbidity;Newborn Morality

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

NON_RANDOMIZED

Intervention Model

SEQUENTIAL

Primary Study Purpose

HEALTH_SERVICES_RESEARCH

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Intervention period

The 1.5-year period during which all six participating centers receive evidence-based collaborative quality improvement interventions including benchmarking, potential better practice list, PDSA implementation, and collaborative learning

Group Type EXPERIMENTAL

Evidence-based collaborative quality improvement

Intervention Type BEHAVIORAL

Evidence-based collaborative quality improvement interventions including benchmarking, potential better practice list, PDSA implementation and collaborative learning

Baseline period

The 2-year period before the collaborative quality improvement intervention

Group Type NO_INTERVENTION

No interventions assigned to this group

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Evidence-based collaborative quality improvement

Evidence-based collaborative quality improvement interventions including benchmarking, potential better practice list, PDSA implementation and collaborative learning

Intervention Type BEHAVIORAL

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

1. Infants born at \>=24+0 weeks' gestation and \<32+0 weeks' gestation;
2. Admitted to the participating NICUs within 7 days after birth during study period